170 Creation of Patient Self-Managed Warfarin Program Within an Anticoagulation Clinic

Introduction:The main purpose of this project is to develop and implement a program for patients to self-manage their warfarin.Methods: Patients were eligible if they had been self-testing their INR for at least 3 months, had an INR goal range of 2-3, were active on MyChart (EPIC's patient messaging system), and were currently using or willing to use 2 mg or 5 mg warfarin tablets.Patients were excluded if they had major bleeding or thrombus in the past three months, had a left ventricular assist device present, lived in a nursing facility, were receiving active cancer treatment, or had a planned procedure in the upcoming three months.A MyChart message was sent to qualifying patients to assess interest in the program.If interested, patients were enrolled in an education class to show how to use the self-management protocol which was adapted from an Anticoagulation Forum protocol.Results: Seventy-one patients were screened for inclusion and exclusion criteria.Seventeen patients were excluded, the most common reason being a planned procedure within the upcoming three months.Of the remaining fifty-four patients, twelve (22%) expressed initial interest in being a part of the pilot program.After further review, one was removed due to a scheduled procedure within three months.The remaining eleven were contacted to further explain the program.Five of the eleven (45%) expressed interest and were enrolled in the education class.Six patients were no longer interested, most commonly due to not wanting to change tablet strengths.Of the five that were interested in being enrolled in the class, two had to change tablet strengths.Data is still being collected on patients completing the education class and the effectiveness of the dosing card for INR self-management.Conclusion: After contacting the interested patients via phone, there was a high rate of program enrollment.